GLP-1 for Weight Loss and Diabetes
US$ 27.57
kidney disease glp-1 news Receptor Agonist Use in Transplant Recipients in: Kidney Volume 17 Issue 8 (2025) Human, exendin-based GLP-1 receptor agonists
Description
Josh Eloge joins the show to explain how medications like Ozempic and Wegovy may impact anxiety, depression, and overall brain chemistry
Currently only half of Cignas clients cover Wegovy and Zepbound due to their high costs.
The studies spanned anywhere from one to four months and recorded an average weight loss of about four and a half kg
Experts are raising concerns about a lesser-known GLP-1 side effect.
A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.
They will offer special nutrition products
